Aktana Welcomes New Medical Affairs Lead from IBM Watson Health (Now Merative) Deepak Patil brings deep data science experience in life sciences to drive Aktana’s medical affairs team in response to growing need for improved healthcare professional engagement SAN FRANCISCO, Sept. 27, 2022 (BUSINESS WIRE) – Aktana, the leader in intelligent customer engagement for the global […]
What can life sciences organizations learn from HCPs on social media? Turns out, a lot. Experts from Aktana, Sermo and Cantab Pi discuss how social media insights are becoming increasingly crucial in supporting omnichannel engagement as the sales model evolves. Read more in Pharmaceutical Executive.
It’s time to scale your digital transformation globally… but how? Check out this recent article by Aktana’s Rakan Sleiman to discover the six key guidelines used by LEO Pharma to create a flexible commercial strategy that successfully cascades down to regions. Read it here.
”AI is no longer a ‘Rolls-Royce’ technology only attainable by organizations with significant resources. Today, AI is for all.” Aktana’s Alan Kalton explores how AI is now impacting the Medical Device industry and why breaking down barriers to adoption is crucial to enhancing business operations moving forward. Read the full article here.
“We’re providing our sales team with the cutting-edge tools needed in today’s market to help them be successful.” Endpoints News highlights results from Almirall’s recent deployment of Aktana’s Contextual Intelligence platform, which has taken pre-call planning down from hours to minutes.
Almirall Deploys Aktana’s Contextual Intelligence 360 to Optimize Pharma Customer Engagement Almirall, LLC achieves 86% user engagement and a dramatic rise in field rep productivity SAN FRANCISCO, May 4, 2022 (BUSINESSWIRE) – Aktana, the leader in intelligent customer engagement solutions for the global life sciences industry, announced that Almirall, LLC selected its Contextual Intelligence Engine for […]
Aktana’s CEO, David Ehrlich, joined David E. Williams on the HealthBiz podcast to talk about his personal connection to the healthcare industry, Aktana’s take on AI, and how Aktana’s advances in contextual intelligence are guiding the life sciences industry through its urgent shift to omnichannel engagement.
The once-upon-a-time hurdles to AI for small to mid-size pharma organizations—cost, tech maturity, and culture—are no longer barriers preventing commercial success. Featuring Vincent Cerio at Almirall, a recent article by Alan Kalton breaks down how new approaches to deploying AI are bringing the cost of ownership down while driving impact, flexibility and accessibility way up.
Aktana’s Jonny Rawlinson shares three tips for designing an omnichannel AI ecosystem that maximizes investments while remaining nimble in today’s dynamic and competitive market. Read the full MedCity News article here.
Aktana’s director of strategic alliances and business development, Jonny Rawlinson, explains how designing an omnichannel AI ecosystem that integrates strategies and tools can maximize commercial success for life sciences companies. Veeva’s vice president of commercial strategy, Andy Fuchs, also weighs in.
